Back to Search
JASON SAVIKKO, D.O.
D.O.
Diagnostic Radiology Physician
NPI: 1649504267IndividualAccepts Medicare
Specialties, Licenses & Credentials
Diagnostic Radiology PhysicianPrimary
Radiology — Diagnostic Radiology
Code: 2085R0202X
8314(AK)
Education
AT STILL UNIVERSITY OF HEALTH SCIENCES, COLLEGE OF OSTEO MED, KIRKSVILLE
Class of 2009
Research & Publications (16)
FK778 ameliorates post-transplant expression of fibrogenic growth factors and development of chronic rejection changes in rat kidney allografts.
PMID 18558624·Nephrol Dial Transplant·2008
7-preclinical
The effect of leflunomide analogue FK778 on development of chronic rat renal allograft rejection and transforming growth factor-BETA expression.
PMID 17175234·Transplant Proc·2006
7-preclinical
Vascular endothelial growth factor (VEGF) ligand and receptor induction in rat renal allograft rejection.
PMID 17175233·Transplant Proc·2006
7-preclinical
Early short-term platelet-derived growth factor inhibition prevents the development of chronic allograft nephropathy in experimental rat kidney transplantation.
PMID 17175231·Transplant Proc·2006
7-preclinical
The effect of FK778 on acute rat renal allograft rejection and expression of platelet-derived growth factor and transforming growth factor-beta.
PMID 17098049·Transplant Proc·2006
7-preclinical
Sirolimus attenuates chronic allograft nephropathy in an experimental rat kidney transplantation model.
PMID 17098043·Transplant Proc·2006
7-preclinical
[Re-expansion of spontaneously collapsed lung and pulmonary edema].
PMID 16268224·Duodecim·2005
5-case
Human polyoma virus in kidney transplants: SV40 T-antigen demonstration in the urine.
PMID 15848583·Transplant Proc·2005
8-other
Leflunomide analogue FK778 is vasculoprotective independent of its immunosuppressive effect: potential applications for restenosis and chronic rejection.
PMID 12923428·Transplantation·2003
4-observational
Chronic allograft nephropathy is prevented by inhibition of platelet-derived growth factor receptor: tyrosine kinase inhibitors as a potential therapy.
PMID 12717194·Transplantation·2003
7-preclinical
Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up.
PMID 12176405·Transplant Proc·2002
7-preclinical
Expression of insulin-like growth factors IGF-I and IGF-II, and their receptors during the growth and megakaryocytic differentiation of K562 cells.
PMID 12127559·Leuk Res·2002
7-preclinical
The effect of acute rejection and cyclosporin A-treatment on induction of platelet-derived growth factor and its receptors during the development of chronic rat renal allograft rejection.
PMID 11889420·Transplantation·2002
7-preclinical
Early induction of platelet-derived growth factor ligands and receptors in acute rat renal allograft rejection.
PMID 11468531·Transplantation·2001
7-preclinical
Expression of platelet-derived growth factor and its receptors in acute rat renal allograft rejection.
PMID 11406219·Transplant Proc·2001
7-preclinical
Coexpression of platelet-derived growth factors AA and BB and their receptors during monocytic differentiation.
PMID 11377539·Transplant Proc·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2741 DEBARR RD, SUITE 401
ANCHORAGE, AK 99508 - Phone
- (907) 792-7975
Quick Facts
- NPI
- 1649504267
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 17
- Publications
- 16
Are you this provider?
Claim Your Profile